Feasibility of Neoadjuvant Ad‐REIC Gene Therapy in Patients with High‐Risk Localized Prostate Cancer Undergoing Radical Prostatectomy-Reference-Cited by-同舟云学术

Feasibility of Neoadjuvant Ad‐REIC Gene Therapy in Patients with High‐Risk Localized Prostate Cancer Undergoing Radical Prostatectomy

Author:

Kumon Hiromi¹,Sasaki Katsumi¹,Ariyoshi Yuichi¹,Sadahira Takuya¹,Araki Motoo¹,Ebara Shin¹,Yanai Hiroyuki²,Watanabe Masami¹³,Nasu Yasutomo¹³

Affiliation:

1. Department of Urology, Okayama University Graduate School of Medicine Dentistry and Pharmaceutical Sciences Okayama Japan

2. Department of Pathology, Okayama University Graduate School of Medicine Dentistry and Pharmaceutical Sciences Okayama Japan

3. Center for Innovative Clinical Medicine Okayama University Hospital Okayama Japan

Funder

KAKENHI

Japan Ministry of Education, Culture, Sports, Science, and Technology

Health Labor Sciences Research Grant of Japan

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

Reference30 articles.

5. REIC/Dkk‐3 as a potential gene therapeutic agent against human testicular cancer;Tanimoto R;Int J Mol Med,2007

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献